Your account is not claimed yet. You can sign up with ORCID to claim your account.

David L Morse

Years Active: 2018-2021
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Narges K Tafreshi, Darpan N Pandya, Christopher J Tichacek, Mikalai M Budzevich, Zhen Wang, Jordan N Reff, Robert W Engelman, David C Boulware, Alberto A Chiappori, Jonathan R Strosberg, Haitao Ji, Thaddeus J Wadas, Ghassan El-Haddad, David L Morse
Preclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms. European journal of nuclear medicine and molecular imaging 48 (11) (2021)
Christopher J Tichacek, Mikalai M Budzevich, Thaddeus J Wadas, David L Morse, Eduardo G Moros
A Monte Carlo Method for Determining the Response Relationship between Two Commonly Used Detectors to Indirectly Measure Alpha Particle Radiation Activity. Molecules (Basel, Switzerland) 24 (18) (2019)
Narges K Tafreshi, Michael L Doligalski, Christopher J Tichacek, Darpan N Pandya, Mikalai M Budzevich, Ghassan El-Haddad, Nikhil I Khushalani, Eduardo G Moros, Mark L McLaughlin, Thaddeus J Wadas, David L Morse
Development of Targeted Alpha Particle Therapy for Solid Tumors. Molecules (Basel, Switzerland) 24 (23) (2019)
Artem R Khabibullin, Aleksandra Karolak, Mikalai M Budzevich, Mark L McLaughlin, David L Morse, Lilia M Woods
Structure and properties of DOTA-chelated radiopharmaceuticals within the 225Ac decay pathway. MedChemComm 9 (7) (2018)

David L Morse.css-eqlu8i{font-size:small;padding-left:4px;}